2415 — MedSci Healthcare Holdings Income Statement
0.000.00%
- HK$562.31m
- -HK$717.46m
- CNY260.62m
- 75
- 72
- 50
- 77
Annual income statement for MedSci Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 216 | 298 | 349 | 349 | 261 |
Cost of Revenue | |||||
Gross Profit | 117 | 190 | 206 | 217 | 162 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 182 | 445 | 445 | 288 | 235 |
Operating Profit | 33.6 | -147 | -95.9 | 60.7 | 25.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 33.2 | -147 | -96.3 | 60.5 | 25.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.9 | -151 | -99.9 | 55 | 25 |
Net Income Before Extraordinary Items | |||||
Net Income | 28.9 | -151 | -99.9 | 55 | 25 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.9 | -151 | -99.9 | 55 | 25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.03 | -0.248 | -0.126 | 0.129 | 0.046 |